Compound Profile: CJC 1295 DAC USA PEPTIDES
CJC 1295 DAC is a modified growth hormone-releasing hormone analogue engineered with Drug Affinity Complex technology for extended pharmacokinetic properties in research applications. This synthetic peptide represents an advanced modification of the native GHRH(1-29) sequence, incorporating strategic amino acid substitutions alongside maleimidopropionic acid conjugation. Researchers investigating growth hormone axis modulation utilise this compound for its prolonged biological activity compared to unmodified GHRH variants. Laboratory studies examine its binding affinity to GHRH receptors and subsequent growth hormone secretion patterns in cellular models. This research chemical enables detailed investigation of pulsatile hormone release mechanisms in controlled experimental conditions. Stroid UK Shop supplies authenticated CJC 1295 DAC for sophisticated endocrine research protocols.
Laboratory Applications
Research teams studying growth hormone physiology examine CJC 1295 DAC’s extended-release characteristics in comparative analyses with native GHRH compounds. The DAC modification creates a stable conjugate that demonstrates altered pharmacokinetic properties in preclinical models, making it valuable for studying sustained hormone secretion patterns. Investigators utilise this peptide in dose-response studies, receptor binding assays, and temporal hormone release experiments. Metabolic research protocols incorporate CJC 1295 DAC to examine growth hormone-insulin-like growth factor axis interactions. Studies focus on understanding the molecular mechanisms underlying modified peptide stability and receptor engagement duration. This compound serves as a reference standard in CJC 1295 peptide research, enabling comparative analysis between DAC and non-DAC variants. Advanced research applications include pharmacokinetic modelling studies and protein-drug conjugate stability investigations.
Technical Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | CJC-1295 with Drug Affinity Complex |
| Molecular Weight | Verify with supplier |
| CAS Number | Verify with supplier |
| Sequence Length | Modified 29 amino acid peptide |
| Storage Temperature | -20°C (lyophilised powder) |
| Solubility | Water soluble |
| Manufacturer | USA Peptides |
| Purity | Research grade |
Laboratory personnel should follow standard peptide handling protocols when working with this research material. Reconstituted solutions require refrigerated storage and prompt utilisation to maintain peptide integrity. Advanced analytical laboratories studying SARMs and peptide interactions may incorporate CJC 1295 DAC in comparative endocrine studies. Research groups investigating peptides utilise this compound for understanding modified GHRH pharmacology and receptor dynamics.
Research Compliance
CJC 1295 DAC from USA Peptides is supplied exclusively for in-vitro laboratory research and analytical testing purposes. This research chemical is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure compliance with local regulations governing peptide research materials and maintain appropriate laboratory safety protocols when handling this compound.
